Abstract:Jue-Xin Wang, 1– 3, &ast Shi-Jia Yu, 4, &ast Gang Huang, 1, 2 Yan-Bo Yu, 1, 2 Yan-Qing Li 1, 2 1 Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong Province, 250012, People's Republic of China; 2 Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong Province, 250012, People's Republic of China; 3 Department of Gastroenterology, The First Affiliated Hospital of Weifang Medical College, Weifang People's Hospital, Weifang, Shandong Province, People's Republic of China; 4 Department of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yan-Bo Yu, Email The intestinal barrier system protects the human body from harmful factors, by continuously renewing the intestinal epithelium, tight junctions and enteric microbes. However, dietary fat can harm the intestinal epithelial barrier enhancing gut permeability. In recent years, Apolipoprotein A-I has attracted much attention because of its anti-inflammatory properties. Numerous studies have demonstrated that Apolipoprotein A-I can regulate mucosal immune cells, inhibit the progression of inflammation, promote epithelial proliferation and repair, and maintain physical barrier function; it can also regulate angiogenesis, thereby improving local circulation. This article is intended to elucidate the mechanism by which Apolipoprotein A-I improves intestinal barrier damage caused by dietary fat and to review the role of Apolipoprotein A-I in maintaining intestinal homeostasis. Keywords: intestinal barrier, apolipoprotein A-I, dietary fat, gut microorganism, angiogenesis The gut is the largest boundary between the human body and the outside environment, with a complex barrier system to protect the body from toxins, bacteria and other potentially harmful substances. 1 It includes continuously renewing intestinal epithelial cells (IECs), tight junctions (TJs), and gut microbes. However, irritants such as those from diet, especially the fat, can breakdown the intestinal barrier, exposing the gut's contents to immune cells in the mucosal layers. 2 These changes will lead to mucosal immune disorder, promote an inflammatory response, damage intestinal structure, and make the body susceptible to various intestinal diseases, such as inflammatory bowel disease (IBD) and infectious diarrhea, etc. 3 Dietary fat has been the focus of studies on intestinal barrier regulation. In a mouse model of IBD, intake of a high-fat diet (HFD) promotes and exacerbates experimental colitis. 4 In humans, a HFD is associated with an increased risk of IBD, possibly due to enhanced mucosal permeability of gut microbes or dietary antigens. 5 Specifically, there is a significant positive correlation between the prevalence of IBD and a country's industrialization status, as the diets of these societies tend to be richer in processed fats and sugars. 6 Therefore, there is a need to understand the molecular mechanisms of dietary fat-mediated intestinal barrier damage. Dietary fat ruins the intestinal barrier in various ways. Most lipolysis products cause permanent damage to the intestinal mucosal barrier by activating the oxidative stress response in intestinal epithelial cells. In addition, it can change the composition of the intestinal mucus layer and regulate the redistribution of tight junction proteins in the luminal surface of the intestinal epithelium. A HFD induces elevated serum levels of lysophosphatidylcholine(LPC). 7 Serum levels of LPC are positively correlated with intestinal barrier damage, which is thought to be associated with changes in intestinal flora. Therefore, unreasonable dietary fat intake can affect the intestinal barrier through oxidation, intestinal flora, IECs and other aspects, thus inducing intestinal diseases and dyslipidemia. 5 Interestingly, intestinal mucosal injury diseases, such as IBD, are often accompanied by differences in the lipid metabolism profile, 8 even in the absence of a long-term high-fat diet. A US study of lipid profiles in 393 IBD patients (152 men and 241 women) found significant reductions in total cholesterol and high-density lipoprotein-C (HDL-C) and significant increases in low-density lipoprotein-C (LDL-C). 9 Studies have also shown that very low-density lipoprotein (VLDL) and HDL synthesis is associated with abnormal lipoprotein and apolipoprotein composition in patients with IBD. 10 The significant decrease in HDL-C is believed to be caused by miss -Abstract Truncated-

Role of Apolipoprotein A-I in Protecting Against Endotoxin Toxicity.

Beneficial effects of ApoA-I on LPS-induced acute lung injury and endotoxemia in mice

Effect of Lipid-Bound Apoa-I Cysteine Mutants on Lipopolysaccharide-Induced Endotoxemia in Mice.

Role of High Density Lipoprotein in Protecting Against Endotoxin Toxicity

The Lipid-Bound Apolipoprotein A-I Cysteine Mutant (N74c) Inhibits The Activation Of Nf-Kappa B, Jnk And P38 In Endotoxemic Mice And Raw264.7 Cells

High Density Lipoprotein‐Lipopolysaccharide Binding Lowers HDL's Basal Antioxidant Capacity

Anti-inflammatory mechanism of Apolipoprotein A-I

Neutrophils Activation Can Be Diminished by Apolipoprotein A-I

Effect of Lipid-Bound Apolipoprotein A-I Cysteine Mutant on ATF3 in RAW264.7 Cells

ApoA‐IV Regulates Cytokine Responsiveness in LPS‐challenged Macrophage Cells

Endogenous ApoA-I expression in macrophages: A potential target for protection against atherosclerosis

Apolipoprotein A Ⅰ inhibit tumor necrosis factor α transcription and expression through JAK2/STAT3 signaling pathway

Apolipoprotein A5 Alleviates LPS/D-GalN-induced Fulminant Liver Failure in Mice by Inhibiting TLR4-mediated NF-κB Pathway.

Lipid-Free Apolipoprotein A-I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio

Apolipoprotein AⅠInhibits Lipid Retention and Apoptosis in Foam Cells via Induction of Autophagy

[Study on the Protective Effect of HDL Subclasses Against Lipopolysaccharide].

Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding scavenger receptor B1

Apolipoprotein A-I: Potential Protection Against Intestinal Injury Induced by Dietary Lipid

A Novel Anti-Inflammatory Mechanism of High Density Lipoprotein Through Up-Regulating Annexin A1 in Vascular Endothelial Cells.

Function of Different Proportions of Apolipoprotein A-I Cysteine Mutants and Apolipoprotein A-V on Recombinant High-Density Lipoproteins in Vitro.

High-density lipoprotein attenuates lipopolysaccharide-induced acute lung injury in mice]